-
PRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc
May 20, 2019
-
PRINCETON, NJ - May 16, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr
May 16, 2019
-
GUILDFORD, UK - May 14, 2019 - In a paper published in the American Chemical Society journal researchers from Bourgogne University showed that the use of superparamagnetic iron oxide nanoparticles (NPs) using multi modal – PET/MRI - showed promising improvements in imaging capabilities
May 14, 2019
-
WESTBURY, NY - May 2, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that its ADME-Tox team has co-authored a second peer-reviewed paper investigating the potential for clinically-relevant botanical-drug interactions (BDIs) with toxicology colleagues at The Procter & Gamble Company (P&G)
May 2, 2019
-
ROYAL OAK, MI, UNITED STATES - Apr 30, 2019 - OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests by harnessing the power of the immune system, today announced the appointment of Mark McDonough as its president, chief executive officer (CEO) and member of the Board of Directors
Apr 30, 2019
-
OXFORD, UNITED KINGDOM, UNITED KINGDOM - Apr 30, 2019 - The significant demand for inflammatory marker laboratory tests in general practice highlights an untapped opportunity for point-of-care diagnostics in the community, suggests research from the NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative
Apr 30, 2019
-
MENLO PARK, CA - Apr 29, 2019 - Avellino Labs, global biotechnology and genetic science innovators, announced today that Eric Donnenfeld, M
Apr 29, 2019
-
LONDON, UK - Apr 29, 2019 -
A study published in
Science Translational Medicine
documents the role played by Clinithink's patented clinical natural language processing platform in delivering genetic diagnoses to neonatal and pediatric intensive care physicians in record breaking time
A new study, published today in Science Translational Medicine, details the pioneering work undertaken by a collaboration led by Stephen Kingsmore, MD, DSc, President and CEO of Rady Children's Institute for Genomic Medicine (RGIGM)
Apr 29, 2019
-
GUILDFORD, UK - Apr 24, 2019 - MR Solutions, of Guildford has achieved a third Queens Award. This follows their win in 2016 with the Queens Award for Enterprise (Innovation), while in 2017 the company was recognised for their excellent performance in International Trade
Apr 24, 2019
-
PRINCETON, NJ - Apr 17, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced four senior executive appointments in its Simcyp division
Apr 17, 2019
-
PRINCETON, NJ - Apr 12, 2019 - The WIRB-Copernicus Group® (WCG) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network (GRN) of investigative sites
Apr 12, 2019
-
PRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying condition
Apr 4, 2019
-
SAN DIEGO, CA - Apr 3, 2019 - ~~BINDING SITEs IMMUNOLOGICALS GROUP is pleased to announce the addition of three (3) new native Bordetella pertussis antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
Apr 3, 2019
-
ATLANTA, GA, UNITED STATES - Apr 1, 2019 -
April 1, 2019 -
ATLANTA
-
OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests, will present results from a feasibility study of a new prostate cancer prognostic assay in a late-breaking poster session at the American Association of Cancer Research (AACR) Annual Meeting tomorrow
Apr 1, 2019
-
WESTBURY, NY - Mar 25, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium
Mar 25, 2019
-
PRINCETON, NJ - Mar 19, 2019 - WIRB-Copernicus Group® (WCG) introduces WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent research sites
Mar 19, 2019
-
WESTBURY, NY - Mar 18, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be co-hosting a one-hour webinar entitled Gaining Clarity: Unique Considerations for the Ethical and Regulatory Use of Human Biospecimens in the European Union (EU) and United Kingdom (UK) at 8 a
Mar 16, 2019
-
HALIFAX, NS, CANADA - Mar 13, 2019 - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its CRYOcheck Factor VIII Inhibitor Kit in the U
Mar 13, 2019
-
PRINCETON, NJ - Mar 13, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its pharmacokinetic/pharmacodynamic (PK/PD), quantitative systems pharmacology (QSP) and physiologically-based pharmacokinetic (PBPK) modeling experts will participate in 21 sessions at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2019 Annual Meeting
Mar 13, 2019
-
REDWOOD CITY, CA, UNITED STATES - Mar 12, 2019 - Cadex Genomics, Corp. announced that it has initiated a pivotal clinical study designed to validate the ability of Alibrex to act as a biomarker for predicting early non-response to therapy in stage IV cancer patients
Mar 11, 2019